Health
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant – DocWire News
Transplantation. 2021 Nov 9. doi: 10.1097/TP.0000000000003983. Online ahead of print.ABSTRACTBACKGROUND: In kidney patients COVID-19…
Transplantation. 2021 Nov 9. doi: 10.1097/TP.0000000000003983. Online ahead of print.
ABSTRACT
BACKGROUND: In kidney patients COVID-19 is associated with severely increased morbidity and mortality. A comprehensive comparison of the immunogenicity, tolerability,…
Continue Reading
-
Business24 hours agoThese ASX 200 shares could rise 50% to 60%
-
General24 hours agoAustralia’s Myanmar community mourns earthquake losses
-
General22 hours agoPeter Dutton partially walks back public service work-from-home vow
-
Noosa News20 hours agoDisaster relief packages announced for flood-stricken western Queensland